New heart valve device offers hope for patients with leaky tricuspid valve
NCT ID NCT07334691
First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 18 times
Summary
This study tests a new device called the Cardiovalve system to replace a leaky tricuspid valve in the heart. It includes 150 people with severe tricuspid regurgitation who are at high risk for open-heart surgery. The goal is to see if the device safely reduces the leak and improves symptoms like shortness of breath and fatigue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Uniklinik Bonn -
RECRUITINGBonn, 53127, Germany
Contact
Conditions
Explore the condition pages connected to this study.